Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence
The Journal of Nervous and Mental Disease, 07/11/2011
Ralevski E et al.
– The objectives of this study were to examine the effect of acamprosate treatment on cognition and to assess whether the changes in drinking patterns or psychotic symptoms were related to changes in cognitive functioning.
23 Outpatients with schizophrenia spectrum disorders and alcohol dependence
Randomized (double-blind) to either acamprosate or placebo treatment for 12 weeks
Assessments (baseline and week 12) included alcohol use, symptoms of psychosis, memory, and attention
Results showed that acamprosate had no effect on cognitive functioning
No relationship between change in alcohol consumption or psychotic symptoms and change in cognitive functioning in this sample of patients
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.